Search for a Cure
Search for a Cure
Coverage of 11th International Congress on Drug Therapy in HIV Infection
- Details
- Category: HIV Treatment
- Published on Saturday, 17 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 11th International Congress on Drug Therapy in HIV Infection (HIV11), November 11-15, 2012, Glasgow, Scotland.
Conference highlights include experimental antiretroviral drugs, ART strategies, manging side effects, HIV-related non-AIDS conditions, treatment as prevention and PrEP, HIV/HCV coinfection, and the search for a cure for HIV.
HIVandHepatitis.com HIV11 conference section
Pegylated Interferon May Maintain HIV Suppression and Reduce Viral DNA Integration
- Details
- Category: Search for a Cure
- Published on Friday, 09 November 2012 00:00
- Written by Liz Highleyman
Adding pegylated interferon alfa to antiretroviral therapy (ART) for HIV may help some people control viral replication when they interrupt treatment, according to a small study reported at this year's Conference on Retroviruses and Opportunistic Infections (CROI 2012) and published in the October 26, 2012, advance online edition of the Journal of Infectious Diseases.
ICAAC 2012: Atazanavir Linked to Kidney Stones in People with HIV
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 September 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, September 9-12, 2012.
Topics highlighted this year include experimental antiretroviral drugs, complications related to HIV and its treatment, recent developments in hepatitis C therapy, cancer caused by HPV, influenza, tuberculosis, and STDs.
HIVandHepatitis.com ICAAC 2012 conference section
ICAAC 2012: Zinc Finger Gene Therapy Leads to Gains in CD4 T-Cells, Especially Memory Cells
- Details
- Category: Search for a Cure
- Published on Thursday, 20 September 2012 00:00
- Written by Liz Highleyman
Gene therapy using a zinc finger nuclease that makes CD4 T-cells resistant to HIV infection led to long-term gains in CD4 cell counts among HIV positive people with poor immunological recovery on antiretroviral therapy (ART), researchers reported at the 52nd Interscience Conference on Antimicrobials and Chemotherapy (ICAAC) last week in San Francisco. Transitional memory T-cells appeared to account for most of the increase.
Coverage of the Interscience Conference on Antimicrobial Agents and Chemotherapy
- Details
- Category: HIV Treatment
- Published on Tuesday, 11 September 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, September 9-12, 2012.
Topics highlighted this year include experimental antiretroviral drugs, complications related to HIV and its treatment, recent developments in hepatitis C therapy, cancer caused by HPV, influenza, tuberculosis, and STDs.
HIVandHepatitis.com ICAAC 2012 conference section
Web Design and Development by